Kimia Biosciences Ltd

Kimia Biosciences Other Announcement

The company filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ended March 31, 2026.

Kimia Biosciences Annual General Meeting

Kimia Biosciences Limited has submitted its notice for the 33rd Annual General Meeting scheduled for September 28, 2026, along with the Annual Report for FY 2025-26.

Kimia Biosciences Board Meeting Outcome

Kimia Biosciences' board meeting outcome includes director appointments, approval of the 33rd AGM notice, and increased borrowing/investment limits. The board also adopted the annual report.

Kimia Biosciences Q1 FY27 Results: Net Profit ₹0.4 Cr, Down 33.3% YoY

Kimia Biosciences Ltd reported revenue from operations of ₹20.7 Cr (-12.3% YoY) and net profit of ₹0.4 Cr (-33.3% YoY) for Q1 FY27.

Key figure

Net profit ₹0.4 Cr · -33.3% YoY

Kimia Biosciences Board Meeting Date

Kimia Biosciences will hold a board meeting on August 10, 2026, to consider and approve its standalone unaudited financial results for the quarter ending June 30, 2026.

Kimia Biosciences Other Announcement

Kimia Biosciences Limited announced changes to its auditor panel, including the cessation of one Secretarial Auditor and the appointment of new Internal, Cost, and Secretarial Auditors.

Kimia Biosciences Board Meeting Outcome

Kimia Biosciences appointed a new Cost Auditor, Internal Auditor, and Secretarial Auditor, while discontinuing the previous Secretarial Auditor following its recent Board Meeting.

Kimia Biosciences Other Announcement

Kimia Biosciences Ltd filed its quarterly shareholding pattern for the period ending June 30, 2026. The filing details holdings across promoter and public categories.